Bolt Biotherapeutics, Inc.

BOLTReported to SECin USCIK 0001641281Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 11. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 11
Form 4 lines at Bolt Biotherapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Yonehiro GrantChief Operating OfficerOpen-market sell$22,1696,850 sharesSep 21, 2026Yonehiro GrantChief Operating Officer$22,169Sell · Sep 21Open-market sell6,850Sep 21, 2026
Yonehiro GrantChief Operating OfficerOpen-market sell$16,2904,909 sharesSep 21, 2026Yonehiro GrantChief Operating Officer$16,290Sell · Sep 21Open-market sell4,909Sep 21, 2026
Yonehiro GrantChief Operating OfficerOpen-market sell$5,3481,417 sharesSep 21, 2026Yonehiro GrantChief Operating Officer$5,348Sell · Sep 21Open-market sell1,417Sep 21, 2026
Nemec SarahSenior VP, Finance and PAOOpen-market sell$13,1954,077 sharesSep 21, 2026Nemec SarahSenior VP, Finance and PAO$13,195Sell · Sep 21Open-market sell4,077Sep 21, 2026
Nemec SarahSenior VP, Finance and PAOOpen-market sell$9,6962,922 sharesSep 21, 2026Nemec SarahSenior VP, Finance and PAO$9,696Sell · Sep 21Open-market sell2,922Sep 21, 2026